The method could be an alternative to opioids and other medication.

Patients prescribed benzodiazepines and opioids by different providers 20% more likely to overdose, adding to already heightened risk.

Study looks at trends before and after 2016 guide for prescribers was released.

The cannabis-derived substance provides fewer side effects, with less potential for abuse.

The findings are a promising step for a disease with limited treatment options.

A new survey shows high usage rates of cannabinoids like CBD for multiple sclerosis, but most patients are figuring out these new products on their own.